Dynavax Technologies
DVAX
#5497
Rank
โ‚ฌ1.09 B
Marketcap
9,35ย โ‚ฌ
Share price
-0.64%
Change (1 day)
-23.72%
Change (1 year)

Dynavax Technologies (DVAX) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ0.45 Billion

According to Dynavax Technologies 's latest financial reports the company has โ‚ฌ0.45 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dynavax Technologies - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ0.57 B1.92%
2023-12-31$โ‚ฌ0.56 B3.89%
2022-12-31$โ‚ฌ0.54 B175.85%
2021-12-31$โ‚ฌ0.19 B311.49%
2020-12-31$โ‚ฌ47.71 M544.82%
2019-12-31$โ‚ฌ7.4 M-86.58%
2018-12-31$โ‚ฌ55.12 M-66.85%
2017-12-31$โ‚ฌ0.16 B96.11%
2016-12-31$โ‚ฌ84.8 M-50.44%
2015-12-31$โ‚ฌ0.17 B107.09%
2014-12-31$โ‚ฌ82.61 M-38.75%
2013-12-31$โ‚ฌ0.13 B55.4%
2012-12-31$โ‚ฌ86.8 M12.87%
2011-12-31$โ‚ฌ76.91 M96.31%
2010-12-31$โ‚ฌ39.17 M780.33%
2009-12-31$โ‚ฌ4.45 M-61.49%
2008-12-31$โ‚ฌ11.55 M-56.88%
2007-12-31$โ‚ฌ26.8 M-55.28%
2006-12-31$โ‚ฌ59.92 M-4.54%
2005-12-31$โ‚ฌ62.77 M42.22%
2004-12-31$โ‚ฌ44.13 M-197.16%
2003-12-31$-โ‚ฌ45.44 Million-15.75%
2002-12-31$-โ‚ฌ53.93 Million38.37%
2001-12-31$-โ‚ฌ38.98 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-โ‚ฌ0.25 Billion-152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ15.63 B 3,308.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ44.57 B 9,617.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ18.42 B 3,916.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ39.47 B 8,506.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚ฌ18.18 B 3,864.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ79.94 B 17,329.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ6.22 B 1,258.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ8.25 B 1,700.85%๐Ÿ‡บ๐Ÿ‡ธ USA